Purpura fulminans in a child with combined heterozygous prothrombin G20210A and factor V Leiden mutations

N Özbek1, F B Ataç2, H Verdi2

  • 1Department of Pediatrics, Başkent University Faculty of Medicine, 6.Cadde No:72/3, 06490, Bahçelievler, Ankara, Turkey. nozbek@tr.net.

Annals of Hematology
|February 26, 2003
PubMed

Insights

Pediatric thrombosis, though rare, is increasing. This case shows a child with severe arterial thrombosis due to combined factor V Leiden and prothrombin G20210A mutations.

Area of Science:

  • Pediatric Hematology
  • Thrombophilia Genetics
  • Vascular Medicine

Background:

  • Thrombosis in children is uncommon but increasingly reported.
  • Genetic mutations like Factor V Leiden (FVL) and Prothrombin G20210A are known risk factors for thrombosis.

Observation:

  • An 8-year-old boy presented with purpura fulminans, characterized by purpuric lesions and penile necrosis.
  • The patient was found to be heterozygous for both the Factor V Leiden (FVL) and Prothrombin G20210A mutations.

Findings:

  • The coexistence of multiple thrombophilic mutations (FVL and Prothrombin G20210A) was identified in a pediatric patient with severe arterial thrombosis.
  • This combination likely contributed to the severe thrombotic event at a young age.

Implications:

  • Highlights the importance of genetic screening for thrombophilia in children with severe thrombosis.
  • Suggests that combined genetic mutations can lead to severe thrombotic manifestations in pediatric patients.
  • Informs clinical management and genetic counseling for pediatric thrombosis cases.